Case report: Personalized management of treatment resistance in advanced NSCLC patients with mutated epidermal growth factor receptor: special examples and literature review

Case report: Personalized management of treatment resistance in advanced NSCLC patients with mutated epidermal growth factor receptor: special examples and literature review

The treatment landscape of non-small cell lung cancer (NSCLC) has shifted significantly from empirical, histology-driven, and clinician-directed cytotoxic regimens to a stratified approach predicated on molecular profiling of tumor genetics and immune biomarkers, by the former can indicate targeted...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Wang, Xiaojing Li, Shuang Dong, Sheng Hu, Fengming Ran, Yu Qian
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
anlotinib
adenocarcinoma
SCLC transformation
TKIs resistance
personalized management
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1525881/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items